Eledon Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 71.1%.

Top 25 shareholders own 35.57% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.1%	BVF Partners L.P.	6,215,942	US$15.5m	43.7%	0.43%
5.97%	Armistice Capital LLC	2,297,000	US$5.7m	-5.97%	0.17%
5.48%	Zimmer Partners, LP	2,109,704	US$5.3m	0%	0.11%
2.52%	The Vanguard Group, Inc.	969,121	US$2.4m	39.4%	no data
1.69%	Woodline Partners LP	651,939	US$1.6m	-5.43%	0.02%
1.15%	Ensign Peak Advisors, Inc.	443,001	US$1.1m	0%	no data
0.47%	Geode Capital Management, LLC	180,901	US$450.4k	2.76%	no data
0.42%	CM Management, LLC	160,000	US$398.4k	14.3%	0.36%
0.26%	Susquehanna International Group, LLP, Asset Management Arm	99,778	US$248.4k	15.6%	no data
0.23%	Next Edge Capital Corp.	90,000	US$224.1k	0%	0.82%
0.23%	Renaissance Technologies LLC	87,069	US$216.8k	25.9%	no data
0.15%	JMAC Enterprises LLC	58,041	US$144.5k	0%	0.03%
0.13%	Ingalls & Snyder, LLC	51,849	US$129.1k	0%	0.01%
0.13%	Schonfeld Strategic Advisors LLC	50,800	US$126.5k	0%	no data
0.12%	State Street Global Advisors, Inc.	44,692	US$111.3k	0%	no data
0.1%	Northern Trust Global Investments	39,804	US$99.1k	-0.24%	no data
0.07%	BlackRock, Inc.	26,831	US$66.8k	-5.2%	no data
0.064%	Marco Investment Management, LLC	24,809	US$61.8k	0%	0.01%
0.043%	Mercer Global Advisors Inc.	16,726	US$41.7k	0%	no data
0.042%	Citadel Advisors LLC	15,982	US$39.8k	-31.1%	no data
0.039%	Charles Schwab Investment Management, Inc.	14,987	US$37.3k	0%	no data
0.036%	Millennium Management LLC	13,875	US$34.5k	-39.3%	no data
0.034%	Pathstone Family Office, LLC	13,029	US$32.4k	0%	no data
0.026%	Paul Little	10,000	US$24.9k	0%	no data
0.023%	David-Alexandre Gros	9,000	US$22.4k	0%	no data